FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndReturn on equity (%) (Million JPY)YoY (%)
Mar 31, 202518.3-125.39%
Mar 31, 2024-72.1+143.40%
Mar 31, 2023-29.6-225.41%
Mar 31, 202223.6+156.35%
Mar 31, 20219.2-139.99%
Mar 31, 2020-23-1756.83%
Mar 31, 20191.4-107.97%
Mar 31, 2018-17.4-10.37%
Mar 31, 2017-19.5+403.10%
Mar 31, 2016-3.9-164.61%
Mar 31, 20156
AI Chat